LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Neratinib
3.1623
7.06 27.76 2 360 0.0056 -0.5091
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
7.06 27.76 569 360 1.5806 1.2636
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
7.06 27.76 19 360 0.0528 -0.0975
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
7.06 27.76 769 360 2.1361 1.4558
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
8.76 27.76 3 401 0.0075 -0.4387
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
8.76 27.76 589 401 1.4683 1.2097
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
8.76 27.76 37 401 0.0922 0.0774
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
8.76 27.76 804 401 2.0043 1.3955
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
10.46 27.76 2 438 0.0046 -0.4834
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
10.46 27.76 621 438 1.4157 1.1825
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
10.46 27.76 38 438 0.0866 0.0821
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
10.46 27.76 836 438 1.9059 1.3516
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
12.17 27.76 3 489 0.0061 -0.4158
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
12.17 27.76 655 489 1.3393 1.1463
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
12.17 27.76 37 489 0.0757 0.0719
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
12.17 27.76 831 489 1.6991 1.2733
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
13.87 27.76 2 604 0.0033 -0.4466
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
13.87 27.76 645 604 1.0666 1.0292
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
13.87 27.76 133 604 0.2199 0.4226
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
13.87 27.76 866 604 1.4321 1.1683
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
15.58 27.76 2 685 0.0029 -0.4337
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
15.58 27.76 647 685 0.9437 0.9751
MN20160318_Q01
D13
MCF 10A-H2B-mCherry Neratinib
3.1623
15.58 27.76 123 685 0.1794 0.3796
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
15.58 27.76 887 685 1.2938 1.1145
MN20160318_Q01
L09
MCF 10A-H2B-mCherry Neratinib
3.1623
17.28 27.76 1 838 0.0012 -0.4913
MN20160318_Q01
D13